News and Trends 27 May 2016
Biotech of the Week: Pharnext, developing next level drugs against Alzheimer’s and Parkinson’s disease
…neurologic indications, like Parkinson’s disease or amyotrophic lateral sclerosis. Comment: Pharnext’ approach of combining existing drugs for new indication is definitely interesting. It reduces the cost of development and ultimately…